000 | 01960 a2200589 4500 | ||
---|---|---|---|
005 | 20250513101237.0 | ||
264 | 0 | _c19961105 | |
008 | 199611s 0 0 eng d | ||
022 | _a0008-543X | ||
024 | 7 |
_a10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEscalante, C P | |
245 | 0 | 0 |
_aDyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world. _h[electronic resource] |
260 |
_bCancer _cSep 1996 |
||
300 |
_a1314-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdrenergic beta-Agonists _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xcomplications |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aDyspnea _xetiology |
650 | 0 | 4 |
_aEmergency Service, Hospital _xstatistics & numerical data |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHealth Resources _xstatistics & numerical data |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLength of Stay |
650 | 0 | 4 |
_aLung Neoplasms _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aManaged Care Programs |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNarcotics _xtherapeutic use |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 | _aOxygen Inhalation Therapy |
650 | 0 | 4 | _aPalliative Care |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTerminally Ill |
700 | 1 | _aMartin, C G | |
700 | 1 | _aElting, L S | |
700 | 1 | _aCantor, S B | |
700 | 1 | _aHarle, T S | |
700 | 1 | _aPrice, K J | |
700 | 1 | _aKish, S K | |
700 | 1 | _aManzullo, E F | |
700 | 1 | _aRubenstein, E B | |
773 | 0 |
_tCancer _gvol. 78 _gno. 6 _gp. 1314-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2 _zAvailable from publisher's website |
999 |
_c8821186 _d8821186 |